tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TEVA Stock Latest News

Teva price target lowered to $29 from $30 at Piper Sandler
The FlyTeva price target lowered to $29 from $30 at Piper Sandler
3h ago
TEVA
TEVA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TEVA Upcoming Earnings Report: What to Expect?
1d ago
TEVA
Teva Pharmaceutical’s Favorable Position in IRA Negotiations Drives Buy Rating
PremiumRatings
Teva Pharmaceutical’s Favorable Position in IRA Negotiations Drives Buy Rating
9d ago
TEVA
Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating
PremiumRatings
Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating
14d ago
TEVA
Teva Pharmaceutical’s Promising Growth Prospects and Strategic Initiatives Drive Buy Rating
PremiumRatings
Teva Pharmaceutical’s Promising Growth Prospects and Strategic Initiatives Drive Buy Rating
20d ago
TEVA
Teva price target lowered to $23 from $24 at UBS
PremiumThe FlyTeva price target lowered to $23 from $24 at UBS
1M ago
TEVA
MedinCell initiated with an Outperform at Evercore ISI
Premium
The Fly
MedinCell initiated with an Outperform at Evercore ISI
1M ago
TEVA
Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating
Premium
Ratings
Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating
1M ago
TEVA
Teva, Fosun Pharma partner to develop TEV-56278
PremiumThe Fly
Teva, Fosun Pharma partner to develop TEV-56278
1M ago
TEVA
Teva, Fosun enter strategic partnership to develop TEV-56278
PremiumThe Fly
Teva, Fosun enter strategic partnership to develop TEV-56278
1M ago
TEVA
Teva put volume heavy and directionally bearish
PremiumThe Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
Teva ‘well positioned for upside from here,’ says JPMorgan
PremiumThe Fly
Teva ‘well positioned for upside from here,’ says JPMorgan
2M ago
TEVA
CrowdStrike and McDonald’s downgraded: Wall Street’s top analyst calls
PremiumThe FlyCrowdStrike and McDonald’s downgraded: Wall Street’s top analyst calls
2M ago
DE
ZM
Teva initiated with a Buy at Goldman Sachs
Premium
The Fly
Teva initiated with a Buy at Goldman Sachs
2M ago
TEVA
Teva Pharmaceutical Elects New Board Members at Annual Meeting
Premium
Company Announcements
Teva Pharmaceutical Elects New Board Members at Annual Meeting
2M ago
8K
TEVA
Teva announces early tender results of debt tender offer
PremiumThe Fly
Teva announces early tender results of debt tender offer
2M ago
TEVA
Teva announces results from a study of treatment patterns of tardive dyskinesia
PremiumThe Fly
Teva announces results from a study of treatment patterns of tardive dyskinesia
2M ago
TEVA
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
PremiumWeekend Updates
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
2M ago
FICO
KYTX
Teva Pharmaceutical’s Promising Long-term Outlook: Buy Rating Backed by Strategic Initiatives and FCF Growth Potential
PremiumRatings
Teva Pharmaceutical’s Promising Long-term Outlook: Buy Rating Backed by Strategic Initiatives and FCF Growth Potential
2M ago
TEVA
Teva reaffirms ‘Pivot to Growth’ strategy with launch of acceleration phase
PremiumThe FlyTeva reaffirms ‘Pivot to Growth’ strategy with launch of acceleration phase
2M ago
TEVA
Teva Pharmaceutical Issues Senior Notes for Debt Management
Premium
Company Announcements
Teva Pharmaceutical Issues Senior Notes for Debt Management
2M ago
8K
TEVA
Teva receives FDA Fast Track designation for TEV-53408, an anti-IL-15 antibody
Premium
The Fly
Teva receives FDA Fast Track designation for TEV-53408, an anti-IL-15 antibody
2M ago
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >